Daicel, Groupe Novasep in chromatography alliance

Article Abstract:

Japan-based Daicel Chemical Industries and France-based Groupe Novasep have announced the formation of a "strategic technical co-operation", wherein Daicel and its worldwide subsidiaries will identify the best chiral stationary phase (CSP) and Groupe Novasep will provide optimization services and process development. A brief overview of the project is presented.

Drugs, Alliances, partnerships, Japan, Biotechnology industry, Biotechnology industries, Alliances and partnerships, Daicel Chemical Industries Ltd.

---

Novasep closes in on Bahamas buy

Article Abstract:

France-based Groupe Novasep is in the final stages of its acquisition deal with Bahamas-based PharmaChem Technologies. PharmaChem manufactures active pharmaceutical ingredients (APIs) and intermediates. The facilities of PharmaChem and Novasep are also discussed.

Acquisitions & mergers, Bahamas, Mergers, acquisitions and divestments, Company acquisition/merger, Specialty chemicals industry

---

Solvay contracts work out to Lonza and Groupe Novasep

Article Abstract:

The manufacturing deals signed by Solvay Pharmaceuticals with Lonza and Groupe Novasep are discussed. Lonza will provide parts of Solvay's Active Pharmaceutical Ingredients (APIs) while Groupe will provide large-scale synthesis of APIs.

Contracts & orders received, Contracts & orders let, United States, Switzerland, Contracts, Lonza AG, Contract agreement, Solvay Pharmaceuticals Inc.

Similar abstracts:

• Abstracts: Defects can increase the melting temperature of DNA-nanoparticles assemblies
• Abstracts: High-resolution optical imaging from trajectory time distributions. Chiral memory on tradition between the B2 and B4 phases in an achiral banana-shaped molecular system
• Abstracts: NMR studies of guest dynamics in clathrate hydrates: spherical tops SF6, SeF6 and CH4 in structure ll hydrate
• Abstracts: ICIG adds two more European sites. Lonza continues global biotech drive. Archimica reborn
• Abstracts: Akzo Nobel Chemicals 'in new phase'. Getting a fairer share. German industry gives backing to white biotech

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.